[{"address1": "One Commerce Square", "address2": "2005 Market Street 39th Floor", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267 866 0311", "website": "https://www.passagebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding \u00df-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. William  Chou M.D.", "age": 52, "title": "President, CEO & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 990111, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen  Borthwick", "age": 48, "title": "Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 604727, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sue  Browne Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stuart M. Henderson", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eden  Fucci", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Whitney Ph.D.", "title": "Senior Vice President of Global Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.08, "open": 9.5, "dayLow": 8.33, "dayHigh": 9.5, "regularMarketPreviousClose": 9.08, "regularMarketOpen": 9.5, "regularMarketDayLow": 8.33, "regularMarketDayHigh": 9.5, "payoutRatio": 0.0, "beta": 1.726, "forwardPE": -1.1730244, "volume": 26689, "regularMarketVolume": 26689, "averageVolume": 62795, "averageVolume10days": 50060, "averageDailyVolume10Day": 50060, "bid": 8.35, "ask": 9.4, "bidSize": 1, "askSize": 1, "marketCap": 27368692, "fiftyTwoWeekLow": 5.124, "fiftyTwoWeekHigh": 20.0, "allTimeHigh": 764.6, "allTimeLow": 5.124, "fiftyDayAverage": 11.67576, "twoHundredDayAverage": 8.467495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1067306, "profitMargins": 0.0, "floatShares": 2857724, "sharesOutstanding": 3178710, "sharesShort": 11220, "sharesShortPriorMonth": 19538, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0034999999, "heldPercentInsiders": 0.00206, "heldPercentInstitutions": 0.52085996, "shortRatio": 0.13, "shortPercentOfFloat": 0.0047999998, "impliedSharesOutstanding": 3178710, "bookValue": 9.79, "priceToBook": 0.8794688, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -45264000, "trailingEps": -14.62, "forwardEps": -7.34, "lastSplitFactor": "1:20", "lastSplitDate": 1752451200, "enterpriseToEbitda": 0.023, "52WeekChange": -0.19616789, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 8.61, "targetHighPrice": 68.0, "targetLowPrice": 10.0, "targetMeanPrice": 39.6, "targetMedianPrice": 32.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 52773000, "totalCashPerShare": 16.602, "ebitda": -45811000, "totalDebt": 24337000, "quickRatio": 2.372, "currentRatio": 2.505, "debtToEquity": 78.204, "returnOnAssets": -0.31655002, "returnOnEquity": -0.87184, "freeCashflow": -19612624, "operatingCashflow": -33474000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PASG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Passage Bio, Inc.", "longName": "Passage Bio, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1582900200000, "postMarketChangePercent": 7.897797, "postMarketPrice": 9.29, "postMarketChange": 0.6800003, "regularMarketChange": -0.47, "regularMarketDayRange": "8.33 - 9.5", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 62795, "fiftyTwoWeekLowChange": 3.4859996, "fiftyTwoWeekLowChangePercent": 0.6803278, "fiftyTwoWeekRange": "5.124 - 20.0", "fiftyTwoWeekHighChange": -11.39, "fiftyTwoWeekHighChangePercent": -0.5695, "fiftyTwoWeekChangePercent": -19.616789, "earningsTimestampStart": 1772571600, "earningsTimestampEnd": 1772571600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -14.62, "epsForward": -7.34, "epsCurrentYear": -11.168, "priceEpsCurrentYear": -0.7709527, "fiftyDayAverageChange": -3.0657606, "fiftyDayAverageChangePercent": -0.26257482, "twoHundredDayAverageChange": 0.14250469, "twoHundredDayAverageChangePercent": 0.016829617, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771633895, "regularMarketTime": 1771621201, "exchange": "NCM", "messageBoardId": "finmb_602462727", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.17621, "regularMarketPrice": 8.61, "displayName": "Passage Bio", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]